May 2017

Important New Products

• Belkyra (deoxycholic acid) is a formulation of synthetically derived deoxycholic acid. ...(more)
• Epiduo Forte (adapalene/ benzoyl peroxide) combines two active substances which act ...(more)
• Grazax (Timothy grass pollen (Phleum pratense) allergen extract) modifies the immune ...(more)
• Stivarga (regorafenib) is an oral antitumour agent that potently blocks multiple protein ...(more)

New Indications

• Afinitor (everolimus) is now indicated for the treatment of progressive, unresectable or ...(more)
• Boostrix (diphtheria/ tetanus/ acellular pertussis (dTpa)) vaccine is now indicated for ...(more)
• Stelara (ustekinumab (rmc)) is now indicated for the treatment of adults with moderately ...(more)
• Zydelig (idelalisib) in combination with ofatumumab is now indicated for the treatment of ...(more)

New Contraindications

• Kaletra (lopinavir / ritonavir) is now contraindicated with the antipsychotic lurasidone.

Safety Related Changes

• Zydelig (idelalisib) can cause serious infections and fatal pneumonitis. The increased ...(more)

Deleted Products
 

• A-Pantoprazole
• APO-Sumatriptan
• Capecitabine Actavis
• Docetaxel Sun 
...(more)

To contact MIMS editorial please email editorial@mims.com.au. To enquire about purchasing a product please contact MIMS Customer service on 1800 800 629 or email subscriptions@mims.com.au. For more information about MIMS, please see www.mims.com.au

 
Copyright © 2017 MIMS Australia Pty Ltd. All rights reserved.
Our mailing address is:
MIMS Australia, Level 2, 1 Chandos Street, St Leonards NSW 2065, Phone: 1800 800 629